Company: PRGO
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001585364-25-000156
Chunk: 113

Company: PERRIGO Co plc
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 7
Chunk 113
---
 recorded in Interest expense, net on a systematic and rational basis. As of September 27, 2025, of the total $2.3 billion notional amount, $515.0 million, $1.0 billion, $300.0 million, $315.0 million, and $200.0 million notional amounts are effective through March 2026, April 2027, September 2028, December 2030, and March 2033, respectively.Other Hedging InstrumentsThe €350.0 million 2032 Notes (as defined in Note 12) are designated as a net investment hedge on our investment in European operations. 

18

Perrigo Company plc - Item 1Note 11

As a designated net investment hedge, gains and losses related to the EUR spot exchange rate will be deferred within the Cumulative Translation Adjustment, a component of AOCI, and recognized in the Condensed Consolidated Statements of Operations when the hedged EUR net investment is substantially liquidated. Foreign Currency ForwardsNotional amounts of foreign currency forward contracts were as follows (in millions):September 27, 2025December 31, 2024United States Dollar (USD)$165.7 $97.9 British Pound (GBP)120.1 101.3 European Euro (EUR)45.1 54.9 Polish Zloty (PLZ)44.0 26.7 Danish Krone (DKK)42.3 57.8 Canadian Dollar (CAD)29.7 35.5 Swedish Krona (SEK)19.0 66.5 Chinese Yuan (CNH)13.0 31.9 Hungarian Forint (HUF)12.8 6.3 Norwegian Krone (NOK)2.5 6.8 Other(1)18.8 16.9 Total$513.0 $502.5 (1) Number consists of notional amounts of various currencies, none of which individually exceed $10.0 million in either year presented.The maximum term of our forward currency exchange contracts is 60 months.On August 1, 2025, we entered into a deal-contingent EUR/USD forward contract of €300 million to hedge foreign exchange risk related to the proceeds expected for the planned divestiture of our Dermacosmetics Business (refer